The essentials
Newborn vitamin K refusals nearly doubled since 2017, raising bleeding risk 81-fold and linked to eight infant deaths in Idaho.
A JAMA study reveals that refusals of the newborn vitamin K injection nearly doubled between 2017 and 2024 in the United States. The shot has been standard medical practice since 1961 and is designed to prevent vitamin K deficiency bleeding in infants.
Newborns who do not receive the injection are 81 times more likely to develop severe bleeding, according to medical data. The consequences have been documented acutely in Idaho, where eight infant deaths attributed to vitamin K deficiency bleeding were reported over a 13-month period.
Researchers also found that parents who refuse the vitamin K shot are more likely to decline additional standard newborn interventions, including the hepatitis B vaccine and prophylactic eye ointment, suggesting a pattern of broader refusal of routine newborn care.
Other ways to read this story.
Alternative framings generated by SigNews. These are not independent sources or attributed quotations.
Declining Refusals Reverse Decades of Infant Safety Progress
Since 1961, vitamin K injections have been a cornerstone of newborn care in the US. The near-doubling of refusals over seven years, combined with eight documented infant deaths in Idaho and an 81-times elevated bleeding risk, signals a measurable erosion of a long-established preventive health standard with direct consequences for infant mortality.
Vaccine Refusal Trend Reflects Broader Parental Decision Patterns
The JAMA data shows that parents declining the vitamin K shot tend to also refuse hepatitis B vaccines and eye ointment, suggesting these decisions are part of a broader approach to newborn care rather than isolated choices. This pattern points to a systemic shift in how a growing segment of parents engage with routine medical interventions at birth.